Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.64 |
| ▸ | RB1 | P06400 | 7/20 | 0.60 |
| ▸ | BRD3 | Q15059 | 10/20 | 0.48 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.44 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.44 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25285965 | 1.00 | CYP2D6 (0.64) | CYP2D6KCNH2RB1BRD3SIRT2 | |
| SCHEMBL25287616 | 0.91 | CYP2D6 (0.76) | CYP2D6KCNH2RB1BRD3SIRT2 | |
| SCHEMBL25247033 | 0.91 | CYP2D6 (0.76) | CYP2D6KCNH2RB1BRD3SIRT2 | |
| SCHEMBL4196180 | 0.91 | CYP2D6 (0.76) | CYP2D6KCNH2RB1BRD3SIRT2 | |
| SCHEMBL30455215 | 0.91 | CYP2D6 (0.76) | CYP2D6KCNH2RB1BRD3SIRT2 | |
| Hydrochloric Acid SCHEMBL4158280 | 0.90 | CYP2D6 (0.74) | CYP2D6KCNH2RB1BRD3SIRT2 | |
| SCHEMBL5455600 | 0.87 | CYP2D6 (0.77) | CYP2D6KCNH2RB1BRD3 | |
| SCHEMBL5458914 | 0.87 | CYP2D6 (0.77) | CYP2D6KCNH2RB1BRD3 | |
| SCHEMBL25286478 | 0.86 | CYP2D6 (0.64) | CYP2D6KCNH2RB1BRD3SIRT2 | |
| SCHEMBL25286477 | 0.86 | CYP2D6 (0.64) | CYP2D6KCNH2RB1BRD3SIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023121238-A1 | SUBSTITUTED HETEROCYCLIC DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME | (주)메디픽 | 2023-06-29 | — | — | WO | disclosed |